Quality control in the manufacturing of therapeutic cells is critical to ensuring that cell-based therapies can be safely and effectively applied. Continuous improvements in detection methods, regulatory frameworks, and manufacturing processes are essential for enhancing the reliability and accessibility of these innovative therapies.

Spectrum FISH can be applied to obtain multi-omics transcriptomic profiles from prepared therapeutic cells without affecting their normal functions, providing a novel quality control approach prior to reinfusion into patients.